In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Washington University's leader on Thursday upped the alarm on proposed funding changes for National Institutes of Health ...

It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, Alzheimer’s research, and other critical health challenges.” ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Feb. 11, the Board of Education of the City of Saint Louis approved a new transportation partnership with Zum to provide ...

For children with signs of neurological conditions such as autism, epilepsy and global developmental delay, genetic testing can help make the diagnosis, identify possible treatments and determine ...

Billions of dollars for medical research remain up in the air for institutions like Washington University. This week, a judge temporarily blocked the Trump administration’s ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

No one was injured when a jet ran off the runway Wednesday at St. Louis Lambert International Airport.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...